Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Using psychological treatments can help manage skin conditions along with regular medical care.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Teen hair loss common in boys, linked to family history and mild symptoms.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Thai people's hair density decreases with age and varies by scalp area, but hair thickness stays the same regardless of age or scalp area.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Mutations in the HEPHL1 gene cause abnormal hair and cognitive issues.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The document concludes that unruly hair can be congenital or acquired, often lacks specific treatments, and can be managed with oils and short hairstyles.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The document concludes that more research is needed to fully understand the causes of PCOS.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

A woman with severe angioedema improved significantly after treatment with rituximab.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.